Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
What are the advantages/disadvantages of using static IMRT vs VMAT when treating breast cancer?
Would you expect a difference in skin reaction?
Related Questions
What volumes would you cover in a young patient with otherwise low risk breast cancer in whom the sentinel node failed to map and ALND was not performed?
How do you incorporate DCISionRT testing in the setting of close (<2 mm) or positive DCIS margins?
In a patient with otherwise favorable DCIS and a focally positive margin who refuses reexcision, is APBI an appropriate treatment option?
How would you approach radiation for an elderly patient with pT2N1 TNBC s/p MRM and ALND who refused chemo-immunotherapy?
In patients with HER-2 positive breast cancer on pertuzumab/trastuzumab with newly developed asymptomatic brain metastases only, do you wait 3 weeks after administration of the targeted therapy to deliver SRS?
When treating APBI with the Florence regimen, are you using daily or every other day fractionation?
Are you comfortable combining palliative radiotherapy with capivasertib/fulvestrant?
In a patient with cardiac comorbidities, who meets ASTRO APBI criteria other than a positive margin, would you offer APBI in an attempt to reduce cardiac dose?
Would you offer APBI to a patient with very large breast anatomy and a small lumpectomy cavity after an oncoplastic closure?
For a young patient with advanced TNBC with a single lung nodule status post NAC, not amenable to biopsy, would you consider SBRT to the lesion?